<DOC>
	<DOCNO>NCT00325130</DOCNO>
	<brief_summary>Data study expect demonstrate V501 ( Human Papillomavirus ( HPV ) [ Types 6 , 11 , 16 , 18 ] Recombinant Vaccine ) , administer concomitantly combine diphtheria , tetanus , pertussis ( Tdap ) vaccine meningococcal conjugate vaccine adolescent remain immunogenic well-tolerated impair immunogenicity concomitant vaccine .</brief_summary>
	<brief_title>Concomitant Use Gardasil ( V501 ) ( Human Papillomavirus Types 6 , 11 , 16 , 18 Recombinant Vaccine ) With Combined Diphtheria , Tetanus , Pertussis Vaccine Meningococcal Conjugate Vaccine Adolescents ( V501-025 )</brief_title>
	<detailed_description />
	<mesh_term>Meningitis</mesh_term>
	<mesh_term>Tetanus</mesh_term>
	<mesh_term>Diphtheria</mesh_term>
	<mesh_term>Whooping Cough</mesh_term>
	<mesh_term>Neoplasms , Glandular Epithelial</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Must healthy boy girl , 1117 year age Must virgin intention become sexually active study period Must properly vaccinate diphtheria , tetanus pertussis Must receive vaccine diphtheria , tetanus pertussis past 5 year Must receive prior human papillomavirus ( HPV ) vaccine meningococcal vaccine</criteria>
	<gender>All</gender>
	<minimum_age>11 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>